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Abstract: Anchor residues, which are deeply buried upon binding, play an important role 
in  protein–protein  interactions  by  providing  recognition  specificity  and  facilitating  the 
binding kinetics.  Up to  now, studies  on anchor residues  have been focused mainly on 
ordered proteins. In this study, we investigated anchor residues in intrinsically disordered 
proteins (IDPs) which are flexible in the free state. We identified the anchor residues of the 
N-terminus of the p53 protein (Glu17–Asn29, abbreviated as p53N) which are involved in 
binding  with  two  different  targets  (MDM2  and  Taz2),  and  analyzed  their  side  chain 
conformations in the unbound states. The anchor residues in the unbound p53N were found 
to  frequently  sample  conformations  similar  to  those  observed  in  the  bound  complexes 
(i.e., Phe19, Trp23, and Leu26 in the p53N-MDM2 complex, and Leu22 in the p53N-Taz2 
complex).  We  argue  that  the  bound-like  conformations  of  the  anchor  residues  in  the 
unbound state are important for controlling the specific interactions between IDPs and their 
targets. Further, we propose a mechanism to account for the binding promiscuity of IDPs in 
terms of anchor residues and molecular recognition features (MoRFs). 
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1. Introduction 
Proteins are the machines of living systems, and their interaction with other molecules is a central 
step to perform functions. Considerable efforts have been devoted to understanding the principles 
governing protein–protein interactions, including interface contacts, morphology, residue conservation, 
and secondary structures [1–5]. In general, the complex interface is not flat, and some residues from 
one protein deeply insert into the binding groove of the partner, resulting in the greatest changes in the 
solvent accessible surface area (SASA) among all the interface residues. Such residues are called 
anchor residues [6]. Anchor residues have been extensively studied, and their critical roles in specific 
molecular recognition processes have been widely addressed [6–12]. The most remarkable feature of 
anchor residues is their conformational preference in the unbound state. All-atom molecular dynamics 
(MD) simulations have shown that anchor residues in the unbound state are in conformations similar to 
those observed in the bound complexes [6,7]. The conformational preference of the anchor residues 
has been successfully applied to improve docking efficiency [9,10]. Recently, Csermely et al. [13] 
figured out an extended view of binding which embraces a repertoire of conformational selection and 
structural adjustment process, where they highlighted the important role of anchor residues in the 
binding process. In their mechanism, conformational selection of the anchor residues in the transient 
encounter process is critical in the stabilization of the encounter complexes due to their large surface 
area. The encounter complexes then undergo further induced-fit to complete the binding event [14]. 
Up to now, studies on anchor residues have been restricted to ordered proteins, i.e., proteins that 
can  be  described  by  defined  three-dimensional  structures.  However,  not  all  proteins  form  unique 
structures in the free state. There exists another special family of proteins—the intrinsically disordered 
proteins  (IDPs)—which  are  flexible  in  the  free  state  and  should  be  described  by  an  ensemble  of 
conformations [15–30].  The  sequence  composition  of  IDPs  is  very  different  from  that  of  ordered 
proteins,  and  therefore  IDPs  can  be  reliably  predicted  through  bioinformatics  studies.  More  than  
60 computational tools have been developed for disorder prediction and many of them have been 
reviewed in reference [31]. IDPs are enriched in cellular functions, such as signaling transduction and 
transcription regulation [26,32,33], and conformational flexibility is extremely important for IDPs to 
interact with their targets [34–38]. In experiments, NMR techniques, small-angle X-ray scattering, and 
different spectroscopic and hydrodynamic methods have been widely used to elucidate the structural 
features  of  IDPs  [39–43],  including  the  molecular  sizes,  secondary  structural  elements,  coupled 
folding-binding processes, and aggregation propensities. In particular, combined with experimentally 
determined restraints, computer simulations have provided the ensemble-level pictures of IDPs [40]. 
Experimental and simulation studies have provided evidence that  specific functional regions of 
IDPs are spatially exposed and may be the primary contact sites in the binding processes [44]. Through 
analysis of complex structures and disorder predictions, short binding regions within long disordered 
sequences were identified and termed as molecular recognition features (MoRFs) [45–48]. MoRFs 
differ from other disordered regions due to their significant secondary structure propensities, and may 
possess preformed structures similar to those in the complex state [49–52]. To form the complexes, 
IDPs use much of their surface to form the interface [47,53,54]; some residues of IDPs insert deeply 
into the binding partners [47,55]. Consequently, these highly buried residues can also be defined as 
anchor residues as those defined in ordered proteins. Although the overall structures of MoRFs have Int. J. Mol. Sci. 2011, 12                       
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been  extensively characterized  [52,56,57],  an  atomic-level  examination of the MoRFs in terms of 
anchor  residues  is  still  missing.  In  addition,  IDPs  are  implicated  in  multiple  interactions  as  their 
structural plasticity allows them to efficiently interact with different targets. So a residue may be an 
anchor residue when binding to one target, whereas in a different protein complex this same residue 
may not be an anchor. Therefore, it would be of significant importance to investigate the behaviors of 
anchor residues when IDPs bind to different targets. 
In  this  study,  we  performed  all-atom  MD  simulations  on  a  helical  region  of  the  N-terminal 
transactivation domain (TAD) of the p53 protein (Glu17–Asn29) (abbreviated as p53N hereafter). p53 
is a transcription factor and is critical in preventing cancer development. The p53N region is the 
binding site of multiple targets, such as MDM2, MDMX, CBP/p300, Taz2, and Bcl-XL [58]. Structure 
analysis has shown that the p53N region is highly disordered with a transient helix structure formed 
within residues Thr18–Leu26 [59–61]. When binding to its targets, e.g., MDM2, the p53N helix is 
prolonged and stabilized [62,63]. Therefore, p53N is a MoRF with a preformed helical structure that 
binds to MDM2. Using p53N as an example of IDPs, we analyzed the side chain conformations of 
anchor  residues  in  the  unbound  state,  and  compared  their  conformations  with  those  in  the  
p53N-MDM2  and  p53N-Taz2  complexes  to  address  the  role  of  anchor  residues  in  the  molecular 
recognition processes. 
2. Results and Discussion 
2.1. Anchor Residues in the p53N Complexes 
p53N  is  versatile  and  interacts  with  multiple  targets.  The  binding  profile  of  p53N  in  the  
p53N-MDM2  complex  was  different  from  that  in  the  p53N-Taz2  complex  (Figure  1).  In  the  
p53N-MDM2  complex,  Phe19,  Trp23,  and  Leu26  were  highly  buried  in  the  binding  groove 
(Figure 1a,d). In contrast, in the p53N-Taz2 complex, only Leu22 was highly buried (Figure 1b,e). 
Structural superposition showed that p53N used different surfaces of a helix structure to bind to these 
two targets  (Figure 1c),  i.e., the p53N helix  rotated  about 90°  in these complexes. So the buried 
residues in the p53N-MDM2 complex (Phe19, Trp23, and Leu26) were exposed to solvent in the 
p53N-Taz2 complex (Figure 1a,b). In globular protein complexes, anchor residues are identified based 
on the structure of the complexes. They correspond to solvent exposed residues that are fully buried 
upon binding to a target, yielding the largest change in SASA [6]. However, for complexes formed by 
IDPs,  the  determination  of  SASA  for  the  unbound  state  may  not  be  so  straightforward,  since  an 
ensemble of conformations instead of a unique conformation are needed to describe the unbound state 
of an IDP. We calculated the SASA for the unbound p53N by two different approaches. The simplest 
one was removing the Taz2 and MDM2 proteins from the p53N-Taz2 and p53N-MDM2 complexes 
and then calculating the SASA of the remaining p53N (Figure 1d,e). We further calculated the SASA 
using the simulated conformations of p53N (Figure S1). In general, different approaches gave similar 
results. According to the initial definition of anchor residues [6], we suggested that anchor residues of 
IDPs should expose to solvent in the unbound state and become fully buried (SASA ≤ 15 Å
2 was used 
here) after binding. Therefore, we identified Phe19, Trp23, and Leu26 as the anchor residues in the 
complex with MDM2, and Leu22 as the anchor residue in the complex with Taz2. It was noted that the 
side chain conformations of Phe19, Leu22, Trp23, and Leu26 in the MDM2 complex were remarkably Int. J. Mol. Sci. 2011, 12                       
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different from those in the Taz2 complex (Figure 1c). Consistent with conformation ensemble of the 
p53 TAD [64], Phe19, Leu22, Trp23, and Leu26 were not buried in our simulated unbound states. 
Figure  1.  The  analysis  of  the  structures  of  p53N  when  bound  to  different  targets.  
(a,b) Complex structures of the p53N-MDM2 complex (a) and p53N-Taz2 complex (b). 
(c) Structure  superposition  of  p53N  from  p53N-MDM2  and  p53N-Taz2  based  on  the 
backbone RMSD. In (a–c), the MDM2 and Taz2 are presented as surface, whereas the 
p53N is presented as ribbon. Phe19, Trp23, and Leu26 are shown as blue balls in (a,b) and 
sticks in (c), Leu22 is shown in red, whereas other residues of the p53N are colored cyan 
(when  in  complex  with  MDM2)  or  green  (when  in  complex  with  Taz2).  (d,e)  SASA 
analysis of the p53N in complex with MDM2 (d) and Taz2 (e). 
 
2.2. Transient Stable Helix of the p53N 
Although  the  p53N  region  is  rather  flexible  in  solution,  experiments  indicate  that  residues  
Thr18–Leu26 form a transiently stable helix which will be further stabilized in the complex state [59]. 
To study the conformational preference of unbound p53N, we conducted multiple simulations on the 
p53N with initial conformations adopted from the p53N-MDM2 and p53N-Taz2 complexes under 
identical conditions (see the Method Section for details). The helical structures were only transiently 
stable and unfolded in the simulations under 300 K (Figures 2 and S2). We defined the unfolding time 
of each trajectory through secondary structure analysis, RMSD relative to the initial helical structure, 
and inspection of the structures (with detailed results in Table S1). The average unfolding time was 
24.5 ±  11.8 ns for the helix from p53N-MDM2 complex and 5.2 ±  3.1 ns for the helix from p53N-Taz2 
complex. Clearly, the helix from the p53N-MDM2 complex was much more stable than that from the 
p53N-Taz2 complex. This may be due to the deformation of the second turn (in the C-terminus) of the Int. J. Mol. Sci. 2011, 12                       
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p53N  helix  from  the  p53N-Taz2  complex,  because  the  unfolding  of  the  p53N  helix  from  either  
p53N-MDM2  or  p53N-Taz2  usually  started  from  the  deformation  of  the  second  turn  during  the 
simulations.  We  also  compared  the  properties  of  our  ensemble  with  those  from  the  Daughdrill’s 
group [64]. Consistent with their results, the distributions of amide nitrogen distances between residues  
i:i + 5 were bimodal, and Phe19–Trp23 showed greater probabilities of collapsed structures (data 
not shown). 
Figure 2. RMSD relative to the backbone of the helical region (Phe19–Leu26) for p53N 
from  p53N-MDM2  (a)  and  from  p53-Taz2  (b)  during  the  simulations.  Simulation 
trajectories MS1–MS5 and TS1–TS5 are presented. 
 
2.3. Analysis of the Side Chain Conformations of the Anchor Residues 
Since the helix of p53N is transiently stable, it is expected that the free energy of the helix state in 
the free form is higher than the disordered state (Figure S3). The free energy barrier of unfolding is 
lower than the free energy barrier of folding, resulting in a greater unfolding rate than a folding rate. 
To obtain conformations of the helix state, we separated the p53N helix from the complex state and 
carried out simulations. The system quickly relaxed to the free energy basin of the helix state and 
probably got equilibrium in the basin before it unfolded to the disordered state (Figure 2). To obtain 
conformations of the disordered state, randomly selected disordered structures were used as initial 
states from simulations. Then the system got equilibrium in the free energy basin of the disordered 
state. No disorder-to-helix transition was observed in simulations. It was noted that this strategy did 
not produce an equilibrium population between the helix state and the disordered state, although it 
gave the distribution of the side chain conformations within each state (Figure 3). 
We  analyzed  the  side  chain  conformations  for  the  helix  state  and  the  disordered  state.  In  our 
simulations, the helix of p53N from the p53N-Taz2 complex unfolded very quickly (~5 ns). Within 
such a short period, conformational sampling of the side chains in the helix state was insufficient. So 
we analyzed the side chain conformations based on the simulations of p53N from the p53N-MDM2 
complex which has a much longer unfolding time. The conformational sampling was found to be more 
efficient in this case. For example, more than 130 transitions were observed between the two main χ2 
conformations of Phe19 and the distribution of the χ2 of Phe19 appeared to be perfectly symmetric 
(Figure 3a) which is required due to the symmetric nature of Phe. Int. J. Mol. Sci. 2011, 12                       
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In this study, we considered two binding targets, so for the four identified anchor residues, each has 
two bound-like conformations: one is an anchor-type (conformations of Phe19, Trp23, and Leu26 in 
the p53-MDM2 complex, and that of Leu22 in the p53-Taz2 complex); the other is a non-anchor 
conformation (conformations of Phe19, Trp23, and Leu26 in the p53-Taz2 complex, and that of Leu22 
in the p53-MDM2 complex). Remarkably, the analysis showed that the anchor residues dominantly 
sampled  the  anchor-type  bound-like  conformations  rather  than  the  non-anchor  bound-like 
conformations regardless of whether the helix or the disordered states were examined (Figure 3 and 
Table 1). The anchor residue with the highest population of the non-anchor bound-like conformation 
was Phe19, but its value was only 12.2% and 6.0% in the helical and disordered states, much smaller 
than the corresponding value of the anchor-type conformation (59.5% and 19.2%). For the other three 
anchor residues, the population of non-anchor bound-like conformation was negligible. It was also 
noted  that  the  formation  of  a  (transient)  helical  structure  enhanced  the  predominance  of  the  
anchor-type bound-like conformations. In the p53N-MDM2 complex, χ1 and χ2 of Phe19 are 177°  and 
71° . The population of this (anchor-type) rotamer increased by a factor of ~2 (i.e., 19.2% vs. 59.5%, 
Table 1), when the p53N transformed from a disordered state to a helix state. Trp23 showed a similar 
trend. Although the extent of the increase was weaker for Leu22 and Leu26, the formation of a helix 
still increased the population of the anchor-type conformations. 
Although the initial structure for simulations was isolated from the p53N-MDM2 complex, Leu22 
sampled  conformations  similar  to  that  in  the  p53N-Taz2  complex  but  not  similar  to  that  in  the  
p53N-MDM2  complex  (Figure  3b  and  Table  1).  Consequently,  the  discrimination  between  the 
populations of the anchor-type and non-anchor bound-like conformations was not caused by a bias of 
the initial states. It could not be solely explained in terms of the side-chain rotamer preferences either: 
rotamer library data [65] indicated that the rotamer of Phe19 preferred the non-anchor bound-like 
conformation (47.08%) rather than the anchor-type (31.71%); however, the trend was reversed in the 
helix state (12.2% vs. 59.5%). The preference of Trp23 on the anchor-type conformation was low in 
the  rotamer  library  (16.21%),  which  was  greatly  enhanced  in  the  helix  state  (62.4%).  These 
observations suggest that the preference of the anchor-type conformations is intrinsic to the transient 
helical structure of the unbound p53N. 
Figure 3 and Table 1 show that the extent of the population shift during the helix-disorder transition 
was similar for Phe19 and Trp23, suggesting synchronous dynamics between these residues. χ1 of 
Phe19 sampled three regions (labeled as A, B, and C in Figure 4a. Due to the symmetric nature of Phe, 
χ2 was not distinguished.). In the χ1–χ2 space, Trp23 sampled six regions (labeled from 1 to 6 in  
Figure 4b). So there were 18 possible combinations of the conformations for Phe19 and Trp23, where 
the  A1 group  was  the  anchor-type  bound-like  conformation  corresponding  to  that  in  the  
p53N-MDM2 complex. The population analysis showed a remarkable feature that the population of 
the  A1  group  (51%)  was  significantly  higher  than  all  other  possible  combinations  (Figure  4c). 
Furthermore,  the  population  of  the  A1  group  was  very  close  to  the  individual  population  of  the  
anchor-type bound-like conformations of Phe19 and Trp23 (59.5% and 62.4%, respectively), showing 
a strong correlation between these two residues. In the helical conformation of p53N, Phe19 and Trp23 
drove (or confined) each other to the anchor-type bound-like conformations. Int. J. Mol. Sci. 2011, 12                       
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Figure 3. Conformational analysis of the anchor residues in the helix state and disordered 
state  of  the  unbound  p53N.  The  bound  conformation  values  in  the  p53N-MDM2  and  
p53N-Taz2 complexes are denoted by red and green markers, respectively. 
 
Table 1. Population of bound-like conformations of anchor residues of the unbound p53N 
in different states. 
Complex compared  State of p53N 
Population of bound-like conformation * 
Phe19  Leu22  Trp23  Leu26 
p53N-MDM2 
Helix  59.5%  –  62.4%  82.7% 
Disordered  19.2%  –  18.7%  76.2% 
Rotamer library  31.71%  3.65%  16.21%  62.52% 
p53N-Taz2 
Helix  12.2%  81.8%  –  – 
Disordered  6.0%  67.1%  –  – 
Rotamer library  47.08%  62.52%  5.32%  <1% 
* ―–‖ indicates the conformation in the bound state does not match a major group in the simulated 
χ1–χ2 distribution. Data for the rotamer library were adopted from Reference [65]. Int. J. Mol. Sci. 2011, 12                       
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Figure 4. Combined analysis of the conformations of Phe19 and Trp23 in the helix state. 
(a) Side chain dihedral distribution of Phe19; (b) Side chain dihedral distribution of Trp23; 
(c) The combination of conformations of Phe19 and Trp23. 
 
We also analyzed the side chain conformations of non-anchor residues, e.g., Glu17, Lys24, Leu25, 
and Glu28 (Figure 5). For Glu17 and Glu28, both bound conformations (in the p53N-MDM2 and 
p53N-Taz2 complexes) were rarely sampled in the helix and disordered states (data not shown) during 
the simulations. Therefore, the conformations of these residues in the complex states were induced by 
interactions with the targets. For Lys24 and Leu25, bound-like conformations were frequently sampled 
in the simulations and the formation of the helix increased the populations. 
Figure  5.  Conformational  analysis  of  non-anchor  residues  in  the  helix  state.  Bound 
conformations  in  the  p53N-MDM2 and  p53N-Taz2  complexes  are  denoted by red and 
green markers, respectively. 
 Int. J. Mol. Sci. 2011, 12                       
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2.4. Transient Formation of Helical Structures Promotes the Binding Process 
Figure  6.  The  roles  of  anchor  residue  conformations  in  the  evolution  of  the  transient 
encounter complex  towards the bound state. (a,b) p53N in a bound-like conformation; 
(c,d) p53N in a distorted conformation; (e,f) p53N in a bound-like conformation. p53N is 
shown as cyan ribbons and the binding targets are shown as surface. Phe19, Trp23, and 
Leu26, are shown as blue sticks. Leu22 is shown as red sticks. 
 
 
Because atomic information of the MoRFs is missing and how/why MoRFs and anchor residues 
initiate  the binding process is  unclear. To  identify the role  of anchor residues and the performed 
structure of MoRFs in the binding processes, we performed binding simulations of p53N to MDM2 
and Taz2. Firstly, we randomly selected five conformations from the A1 group (Figure 4) as initial 
conformations of the p53N. Then, we placed the p53N close to the binding groove of MDM2 with the 
correct orientation (Figure 6a). This was to mimic the encounter of the two proteins. In these encounter 
states, the anchor residues did not insert into the binding groove. Based on these in silico encounter 
states,  we  conducted  MD  simulations  to  track  the  evolution  process.  As  expected,  after  the  local 
conformational rearrangements on the binding groove of MDM2, Phe19, Trp23, and Leu26 inserted 
into the binding groove within ~1 ns (Figure 6b). This result is consistent with the observations of 
binding the native p53N to MDM2 [66], because conformations in the A1 group were native-like. Our 
results confirm the validity of results which are based on the prerequisite that p53N is in a bound 
conformation during the encounter process [66,67]. Furthermore, we also performed simulations with 
the p53N in other conformations, e.g., conformations from the B3 group and the disordered states. 
Within  10  ns  of  simulations,  p53N  did  not  evolve  towards  the  bound  conformations  but  formed  
non-native interactions with MDM2 (Figure 6c,d). The same conformations of p53N above were also Int. J. Mol. Sci. 2011, 12                       
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used to simulate binding of p53N to Taz2. For p53N in the helix state (i.e., conformations from the A1 
group  and  B3  group),  Leu22  inserted  into  the  binding  groove  quickly;  however,  the  correct 
conformations of Phe19 and Trp23 were not observed within 10 ns (Figure 6e,f). This was due to the 
steric constraints at the binding interface. Therefore, induced formation of the correct conformations of 
Phe19 and Trp23 may take longer. For p53N in the disordered state, only non-native interactions 
between p53N and Taz2 were observed. 
Although experimental and computational studies have shown that MDM2 undergoes structural 
rearrangement,  in  particular  in  the  binding  groove,  upon  the  p53N  binding  [66,68],  it  does  not 
contradict the concept of a preformed bound-like conformation of the unbound p53N. On the contrary, 
the bound-like conformation of p53N in the unbound state actually promotes the groove opening of the 
unbound MDM2 [66]. Furthermore, the important roles of Phe19, Trp23, and Leu26 in the binding 
process of p53N with MDM2 and Leu22 in the binding process of p53N with Taz2 have been studied 
thermodynamically  [69,70];  however,  their  roles  in  the  kinetic  process  is  not  clear.  In  this  work, 
through  simulations,  we  found  that  preformed  bound-like  conformations  of  these  anchor  residues 
promoted the binding process. 
2.5. Discussions: Roles of Anchor Residues in Molecular Recognition 
In  this  study,  we  tried  to  extend  the  concept  of  anchor  residues  to  IDPs  and  understand  the 
conformational properties of the anchor residues within a highly flexible context. To this end, we 
performed atomic MD simulations on an extensively studied system, the p53N region. In the unbound 
state, p53N is rather flexible; however, once the helix is partially and transiently formed, simulations 
showed that the anchor residues were restricted to their anchor-type bound-like conformations and 
were primed for interacting with their targets (Figures 3 and 4, and Table 1). 
A comparison of the bound conformations of the anchor residues and non-anchor residues with the 
rotamer library derived from the Protein Data Bank [65] further supports the concept that anchor 
residues  adopt  preformed  bound-like  conformations  (Table  1).  In  the  p53N-MDM2  complex,  the 
conformations of the anchor residues (Phe19, Trp23, and Leu26) represent the major conformations in 
the rotamer library, whereas the conformations of Glu17, Leu22, and Glu28 exhibit very low values in 
the rotamer library. Conversely, in the complex p53N-Taz2, the conformation of Leu22 is the major 
conformation  in  the  library,  whereas  the  conformations  of  Trp23  and  Leu26  exhibit  very  low 
populations.  The  formation  of  rare  rotamers  is  induced  by  interactions  between  p53N  and  the 
targets [71]. 
Significant efforts have been made to identify the structure of MoRFs and understand the molecular 
recognition processes between IDPs and their binding targets. Experimental and computational studies 
have shown that preformed structures of MoRFs in the unbound state resemble structures in the bound 
complexes  and  therefore  facilitate  the  recognition  processes  [49,51,52,57,59,72–75].  However,  the 
roles of MoRFs in the molecular recognition processes remain elusive. In this study, we extended the 
understanding through an investigation of the correlation between the side chain conformations and the 
overall structure of MoRFs. We suggest that, as in globular proteins, anchor residues also exist in IDPs 
and are important in the specific molecular recognition processes. Since the side chain conformations 
are backbone dependent, the preformed structure of MoRFs in the unbound state provides a constraint Int. J. Mol. Sci. 2011, 12                       
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on the side chain conformations to produce bound-like anchor residues. A recent study showed that the 
conformational  preference  of  residues  in  a  disordered  20-mer  peptide  was  closely  correlated  to 
inhibitory activity [76]. Recently, Kjaergaard et al. determined the core structure of a molten globule 
by NMR and found that the side chain of some hydrophobic residues had preferred rotamers and made 
specific interactions [77]. Characterization of the MoRFs of Sendai virus nucleoprotein also showed 
that the transient formation of a helix optimized the interaction with the negatively charged cleft on the 
surface of the phosphoprotein PX domain [73]. These results support the concept that particular key 
residues in IDPs have preferred (function-related) conformations in the unbound state. 
Combined  with  the  concepts  of  MoRFs  and  anchor  residues,  a  feasible  mechanism  of  the 
recognition process between a disordered binding region and its target emerges. For example, in the 
binding process of p53 to MDM2, the binding is initiated by an encounter between the preformed 
bound-like MoRF of p53 and MDM2, which will produce a transient encounter complex. Insertion of 
the preformed bound-like anchor residues (Phe19, Trp23, and Leu26), which are located on the MoRF, 
into the binding groove of MDM2 stabilizes the transient encounter complex (Figure 6a,b). Further 
folding  of  the  backbone  and  induced-fit  of  the  side  chains  take  place  to  finally  form  the  native 
complex. Therefore, in this mechanism, a binding process between an IDP and its target is initiated by 
a  conformational  selection  and  then  proceeds  by  folding  upon  binding  [51,75].  In  the  simulated 
binding process of proline-rich motifs to SH3 domains, electrostatic interactions guide the diffusion to 
form a nonspecific encounter complex state which is stabilized by subsequent anchoring of an arginine 
of the peptide into the negatively charged groove of the SH3 domain [78]. This gives some support to 
our proposed mechanism. 
To account for the specific recognition process, various mechanisms have been proposed, including 
the  lock-and-key  model  [79],  the  induced-fit  mechanism  [80],  and  the  conformational  selection 
model [81,82].  Recently,  Boehr  et  al.  proposed  a  general  mechanism  constituted  by  a  primary 
conformational selection event followed by an induced-fit of side chains and the backbone to account 
for  the  role  of  dynamics  in  the  biomolecular  recognition  process  [83].  Similarly,  Csermely  et  al. 
figured out an extended view of binding which embraces a repertoire of selection and adjustment 
processes [13]. All these mechanisms mainly focus on ordered proteins and the discussions on IDPs 
are very limited. Our study adds important insights into the molecular recognition mechanisms and 
extends them to molecular interactions involving IDPs. 
IDPs have been proposed to have the ability to bind to multiple targets [38] and p53 is a typical 
example. The N-terminus of p53 binds MDM2, MDMX, Taz2, and Bcl-XL, while the C-terminus of 
p53 interacts with S100ββ, Sirtuin, CBP, and Cyclin A2 [58]. SASA analysis shows that p53N uses 
different anchor residues to bind to different targets (Figure 1). Forming a complex with MDM2, 
Phe19, Trp23, and Leu26 are the anchor residues, whereas binding with Taz2, Leu22 is the anchor 
residue. By analyzing the complex structures, Oldfield et al. found that the same residues from the  
C-terminus  of  p53  are  used  to  a  different  extent  in  binding  to  different  targets  and  interactions 
involving  the  same  residue  may  exclude  each  other  in  different  complexes  [55].  Our  simulations 
showed that, in the helix state of unbound p53N, Phe19, Trp23, and Leu26 significantly sampled 
conformations similar to those in the complex with MDM2, whereas Leu22 sampled conformations 
similar to that in the complex with Taz2 (Figures 3 and 4, Table 1); these indicate a new mechanism to 
account for the binding promiscuity of IDPs. It is possible that all the anchor residues in the MoRFs Int. J. Mol. Sci. 2011, 12                       
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frequently sample the bound conformations of the corresponding targets and that a particular target 
selects  a  particular  group  of  anchor  residues  in  the  binding  process.  This  binding  mechanism  is 
advantageous in smoothing molecular interactions [84], and reconciles the binding promiscuity and 
binding kinetics in the binding process and provides a clearer picture for the one-to-many signaling 
processes where flexibility has been considered as the main source [55,85,86]. A similar mechanism 
has been proposed to interpret the structural basis of pregnane X receptor binding promiscuity, where 
the pregnane X receptor has five hot spot regions and, depending on their sizes and shapes, individual 
PXR ligands extend into two, three, or four hot spot regions [87]. 
To extend the mechanism obtained from p53N to other IDPs, great efforts are still required. For 
example, because not all MoRFs adopt helical conformations [46,47], whether the non-helical MoRFs 
have  preformed  structures  or  anchor  residues  in  these  non-helical  MoRFs  also  adopt  bound-like 
conformations is unclear. It would also be valuable to experimentally test the side chain conformational 
preference observed in our simulations. 
3. Method Section 
3.1. Systems Setup 
A series of simulations were performed based on the p53 N-terminal domain (Glu17–Asn29, p53N) 
(Table S1). Initial conformations for MD simulations were taken from the p53N-MDM2 complex 
(PDB  ID  1YCR)  [62]  (trajectories  MS1–MS10),  the  p53N-Taz2  complex  (PDB  ID  2K8F)  [88] 
(trajectories  TS1–TS5),  or  the  disordered  state  of  unbound  p53N  (trajectories  DS1–DS5).  The 
disordered states of unbound p53N were randomly selected snapshots ranging from 60 ns to 100 ns in 
the trajectory MS1. The duration for each trajectory varied between 20 and 100 ns (see Table S1). In 
the  binding  simulations,  we  randomly  selected  five  conformations  from  the  A1  group,  B3  group 
(Figure 4), and the disordered state, respectively, as initial conformations of p53N; then we placed 
p53N close  to the binding groove of MDM2 or Taz2 with the correct orientation (Figure 6). All 
binding simulations lasted for 10 ns. 
3.2. Molecular Dynamics Simulations 
The  MD  simulations  were  performed  using  the  program  GROMACS  4.07  [89,90]  and  the  
OPLS-AA/L force field [91]. The water molecules were modeled by the SPC/E representation [92]. 
Each of the starting conformations was placed in the center of a cubic water box with at least 10 Å 
from the box edge. Periodic boundary conditions were used. Counter ions (Na
+ or Cl
−) were added to 
neutralize the net charges. The long-range electrostatic interactions were treated with the particle mesh 
Ewald method [93]. The cutoff distances were set to 10 Å for short-range coulomb and van der Waals 
interactions. The bond lengths were fixed by the LINCS algorism [94], and a time step of 2 fs was 
used. Coordinates were saved every 5 ps. 
Each system was first relaxed by 1000 steps of the steepest-descent energy minimization. After the 
minimization, the system was equilibrated at 300 K by 100 ps under an NVT ensemble and further 
equilibrated for 200 ps at constant pressure (1 bar). V-rescale [95] and Parrinello-Rahman [96] were 
used to couple the system to the simulation temperature and pressure with coupling constants of 0.1 ps Int. J. Mol. Sci. 2011, 12                       
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and 2.0 ps, respectively. Production simulations were performed at constant temperature (300 K) and 
pressure (1 bar). 
3.3. Analysis 
Secondary  structure  analysis  was  assigned  by  the  DSSP  program  [97].  NACCESS 
(http://wolf.bms.umist.ac.uk/naccess/) was used to calculate the SASA, using a default solvent probe 
radius of 1.4 Å. We monitored the side chain dihedral angles (χ1 and χ2) distribution of anchor residues 
in the helix state and disordered state. χ1 is defined by N-Cʱ-Cβ-Cγ and χ2 is defined by Cʱ-Cβ-Cγ-Cʴ(1). 
Protein figures were produced by the VMD program [98]. 
4. Conclusions 
In this study, we identified the anchor residues of the disordered p53N when binding to different 
targets, i.e., Phe19, Trp23, and Leu26 for the p53N-MDM2 complex, and Leu22 for the p53N-Taz2 
complex. From the all-atom simulations of the unbound p53N, we found that, as in ordered proteins, 
these anchor residues in p53N frequently sampled conformations similar to those in the complex states 
where anchor residues act as anchors, but seldom sampled those in the alternative complexes. We 
suggest that the bound-like conformations of anchor residues in the unbound state are an important 
factor in controlling the specific interaction between IDPs and their targets, in particular, stabilizing 
the transient encounter complexes. We also propose a new mechanism to account for the binding 
promiscuity of IDPs. 
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Supplementary Materials 
Figure S1. SASA analysis of the p53N in the disordered state (a,c) and the helix state 
(b,d) using the simulated trajectories. For comparison, the corresponding values of SASA 
in the complex states are presented. 
 Int. J. Mol. Sci. 2011, 12                       
 
 
1429 
Figure S2. Secondary structure analysis of p53N from p53N-MDM2 (a) and p53-Taz2 (b) 
during simulations. Simulations MS1–MS5 and TS1–TS5 are presented. 
 
Figure  S3.  Schematic  free  energy  landscape  of p53N. The orange  arrow indicates  the 
relaxation of the initial complex structure to the helix state. The two green arrows indicate 
the transitions between the helix state and the disordered state. 
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Table S1. Details of the simulations. 
Simulations  Initial 
Conformation
* 
Simulation Duration (ns)  Unfolding  Time 
(ns) 
MS1  M  100  43 
MS2  M  20  11 
MS3  M  100  42 
MS4  M  100  25 
MS5  M  20  17 
MS6  M  60  28 
MS7  M  20  10 
MS8  M  20  15 
MS9  M  60  23 
MS10  M  60  31 
TS1  T  20  2 
TS2  T  20  4 
TS3  T  20  3 
TS4  T  20  9 
TS5  T  20  8 
DS1  D  50  - 
DS2  D  50  - 
DS3  D  50  - 
DS4  D  50  - 
DS5  D  50  - 
* M denotes the initial p53N structure from p53N-MDM2 complex; T for the initial p53N structure 
from p53N-Taz2 complex; D for the disordered state. 
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